183 related articles for article (PubMed ID: 22429006)
1. Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.
Schiefer IT; VandeVrede L; Fa' M; Arancio O; Thatcher GR
J Med Chem; 2012 Apr; 55(7):3076-87. PubMed ID: 22429006
[TBL] [Abstract][Full Text] [Related]
2. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
Bon CL; Garthwaite J
Eur J Neurosci; 2001 Aug; 14(4):585-94. PubMed ID: 11556884
[TBL] [Abstract][Full Text] [Related]
3. Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.
Horton A; Nash K; Tackie-Yarboi E; Kostrevski A; Novak A; Raghavan A; Tulsulkar J; Alhadidi Q; Wamer N; Langenderfer B; Royster K; Ducharme M; Hagood K; Post M; Shah ZA; Schiefer IT
J Med Chem; 2018 May; 61(10):4593-4607. PubMed ID: 29683322
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.
Boulton CL; Southam E; Garthwaite J
Neuroscience; 1995 Dec; 69(3):699-703. PubMed ID: 8596640
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
[TBL] [Abstract][Full Text] [Related]
7. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
9. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
[TBL] [Abstract][Full Text] [Related]
10. On the role of nitric oxide in hippocampal long-term potentiation.
Bon CL; Garthwaite J
J Neurosci; 2003 Mar; 23(5):1941-8. PubMed ID: 12629199
[TBL] [Abstract][Full Text] [Related]
11. Blood-Brain Barrier Permeable and NO-Releasing Multifunctional Nanoparticles for Alzheimer's Disease Treatment: Targeting NO/cGMP/CREB Signaling Pathways.
Liu Z; Liu Q; Zhang B; Liu Q; Fang L; Gou S
J Med Chem; 2021 Sep; 64(18):13853-13872. PubMed ID: 34517696
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase.
von Wantoch Rekowski M; Pyriochou A; Papapetropoulos N; Stössel A; Papapetropoulos A; Giannis A
Bioorg Med Chem; 2010 Feb; 18(3):1288-96. PubMed ID: 20036129
[TBL] [Abstract][Full Text] [Related]
13. An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk.
VandeVrede L; Abdelhamid R; Qin Z; Choi J; Piyankarage S; Luo J; Larson J; Bennett BM; Thatcher GR
PLoS One; 2013; 8(8):e70740. PubMed ID: 23976955
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel senkyunolide analogues as neuroprotective agents.
Fang Y; Wang R; Wang Q; Sun Y; Xie S; Yang Z; Li M; Jin Y; Yang S
Bioorg Med Chem Lett; 2018 Feb; 28(4):668-672. PubMed ID: 29370975
[TBL] [Abstract][Full Text] [Related]
15. Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat.
Sardo P; Carletti F; D'Agostino S; Rizzo V; Ferraro G
J Neural Transm (Vienna); 2006 Dec; 113(12):1855-61. PubMed ID: 16736237
[TBL] [Abstract][Full Text] [Related]
16. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].
Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN
Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
18. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
[TBL] [Abstract][Full Text] [Related]
20. Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.
Luo J; Lee SH; VandeVrede L; Qin Z; Piyankarage S; Tavassoli E; Asghodom RT; Ben Aissa M; Fà M; Arancio O; Yue L; Pepperberg DR; Thatcher GR
BMC Neurosci; 2015 Oct; 16():67. PubMed ID: 26480871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
